MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-02-0011378
Vip Pharmaceuticals Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.07 Cr
▲ 6% YoY
Net profit · FY 2025
₹1.51 Cr
Net margin 3.8%
EBITDA · FY 2025
₹2.81 Cr
EBITDA margin 7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹8.98 Lakh
Issued & subscribed
Open charges
₹2.99 Cr
Satisfied ₹1.13 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
21
Provident fund records
About Vip Pharmaceuticals Private Limited
Data last updated:
Vip Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 September 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2000PTC107962. Its GSTIN is 07AABCV3751D2ZJ (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹8.98 Lakh. It is led by directors Deepak Kumar and Sunita Rani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B 6 7 Gali No 13 Madhu Vihar, New Delhi, Delhi, India – 110002.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.07 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹1.51 Cr (net margin 3.8%) and EBITDA of ₹2.81 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 18% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: VIP Pharmaceuticals. As per MCA filings, the company has open charges of ₹2.99 Cr and satisfied charges of ₹1.13 Cr on record. Court records list 15 cases involving the company, including 5 filed by the company and 10 filed against it; 4 cases are pending.
Vip Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0011378). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vippharma.co.in.
Company details
CIN U24239DL2000PTC107962
Registration Number 107962
Incorporation Date 29 September 2000
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-02-0011378
Recognitions & Rankings of Vip Pharmaceuticals
Contact details
Vip Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its website is vippharma.co.in. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressB 6 7 Gali No 13 Madhu Vihar, New Delhi, Delhi, India – 110002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vip Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Vip Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vip Pharmaceuticals operates one associated brand: VIP Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations, offers branded generics and contract manufacturing services globally. | vippharma.co.in |
Business activity
The main business activity of Vip Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vip Pharmaceuticals Private Limited, buy the company report.
Financials of Vip Pharmaceuticals Private Limited
FY 2025 filings availableVip Pharmaceuticals Private Limited reported revenue of ₹40.07 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹40.07 Cr ▲ 6%
Net profit · FY 2025
₹1.51 Cr margin 3.8%
EBITDA · FY 2025
₹2.81 Cr margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 17%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 23%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 6% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.81 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.51 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vip Pharmaceuticals Private Limited, buy the company report.
Board of directors of Vip Pharmaceuticals Private Limited
Vip Pharmaceuticals has 2 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Kumar | Director | 01 Sep 2022 | 4 Years 2 Months | Current |
| Sunita Rani | Additional Director | 07 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Vip Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alkimia Pharma-Chem Private Limited | ₹40.2 Cr (FY 2025) | 975.0% | Hyderabad, Telangana, India | |||
| Integrated Laboratories Private Limited | ₹40.11 Cr (FY 2024) | 24.0% | Sirmour, Himachal Pradesh, India | |||
| Vip Pharmaceuticals Private Limitedthis company | ₹40.07 Cr (FY 2025) | ₹1.51 Cr | 3.8% | 6.0% | 21 | New Delhi, Delhi, India |
| Meditab Specialities Limited | ₹40.03 Cr (FY 2025) | -90.0% | Mumbai, Maharashtra, India | |||
| Stellar Formulations Industries Private Limited | ₹39.96 Cr (FY 2025) | 11.0% | Vadodara, Gujarat, India | |||
| Zenith Enzymatic Drugs Private Limited | ₹39.93 Cr (FY 2024) | 6.0% | Pune, Maharashtra, India | |||
| Vanelloid Private Limited | ₹39.6 Cr (FY 2024) | 11.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Vip Pharmaceuticals Private Limited, buy the company report.
Auditor
Vip Pharmaceuticals Private Limited is audited by VISHWA MITTER & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VISHWA MITTER & CO | FY 2020 | 005372N |
Shareholding
The shareholding of Vip Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Vip Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.99 Cr
Satisfied charges
₹1.13 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Apr 2022 | 100560181 | Hdfc Bank Limited | ₹2.99 Cr | Open | |
| 19 Feb 2015 | 10559471 | Vijaya Bank | ₹60 Lakh | Satisfied | |
| 14 Aug 2007 | 10069586 | Vijay Bank | ₹30 Lakh | Satisfied | |
| 07 Apr 2006 | 10077153 | Vijay Bank | ₹14 Lakh | Satisfied | |
| 06 Mar 2001 | 90048372 | Bank of Baroda | ₹8.5 Lakh | Satisfied |
To see the full charge records of Vip Pharmaceuticals Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
Vip Pharmaceuticals Private Limited has 15 court cases on record: 5 filed by Vip Pharmaceuticals, 10 filed against it. 4 cases are pending and 11 are disposed.
Total cases
15
Filed by the company
5
Filed against the company
10
Pending
4
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 8 | 3 |
| High courts | 4 | 2 | 1 |
Cases on record (5 of 15)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Rhydburg Pharmaceuticals Limited | Pending |
| District court, Ludhiana, Punjab | Commercial suit | Filed against the company by M/S Iol Chemicals and Pharmaceuticals Ltd | Pending |
| District court, Panchkula, Haryana | Execution petition | Filed against the company by M/S Dove Chemicals Ltd ( Dove Research and Analytics, A Unit of Dove Chemicals Limited) | Disposed |
| High Court of Delhi | Court case (FAO (COMM)) | Filed against the company by Rhydburg Pharmaceuticals Limited | Disposed |
| High Court of Delhi | Commercial suit | Filed by the company against Rhydburg Pharmaceuticals Limited | Disposed |
To see the full case history of Vip Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vip Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vip Pharmaceuticals Private Limited has a workforce of 21 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
21
Active EPFO establishments
1
Employee growth
-25%
GST
Vip Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCV3751D2ZJ | Delhi | Active | 08 Mar 2020 |
| 02AABCV3751D1ZU | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vip Pharmaceuticals Private Limited, buy the company report.
Recent activity
Vip Pharmaceuticals Private Limited has 10 board changes on record since 2010: 3 appointments and 7 cessations. The latest: Sunita Rani was appointed as Additional Director on 07 Mar 2025.
AGM
Vip Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vip Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Sunita Rani was appointed as Additional Director.
Appointed
Naresh Kumar was appointed as Additional Director.
Ceased
Kanika Singla ceased to be Additional Director.
Appointed
Deepak Kumar was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 298.50 Lakh with Charge ID 100560181 was registered on 16 Apr 2022.
Charges
A charge registered on 06 Mar 2001 via Charge ID 90048372 with Bank Of Baroda was fully satisfied on 28 Jun 2021.
Ceased
Ram Awadh ceased to be Director.
Charges
A charge registered on 19 Feb 2015 via Charge ID 10559471 with Vijaya Bank was fully satisfied on 29 Feb 2020.
Charges
A charge registered on 14 Aug 2007 via Charge ID 10069586 with Vijay Bank was fully satisfied on 29 Feb 2020.
Charges
A charge registered on 07 Apr 2006 via Charge ID 10077153 with Vijay Bank was fully satisfied on 29 Feb 2020.
10 earlier events are in the company report.
Frequently asked questions
Vip Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 September 2000 (26+ years old) and is registered under CIN U24239DL2000PTC107962.
Vip Pharmaceuticals has 2 current directors:
- Deepak Kumar - Director
- Sunita Rani - Additional Director
The latest financial statements of Vip Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vip Pharmaceuticals is 07AABCV3751D2ZJ, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02AABCV3751D1ZU (Himachal Pradesh).
The CIN (Corporate Identification Number) of Vip Pharmaceuticals is U24239DL2000PTC107962. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vip Pharmaceuticals has 15 court cases on record: 5 filed by the company and 10 filed against it. 4 are pending. Most are in the district courts.
Vip Pharmaceuticals was incorporated on 29 September 2000, making it 26+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Vip Pharmaceuticals by revenue are Alkimia Pharma-Chem Private Limited, Integrated Laboratories Private Limited, Meditab Specialities Limited, Stellar Formulations Industries Private Limited, Zenith Enzymatic Drugs Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sunita Rani was appointed as Additional Director on 07 Mar 2025. Naresh Kumar was appointed as Additional Director on 01 Jan 2023. Kanika Singla ceased to be Additional Director on 30 Sep 2022. Vip Pharmaceuticals has 10 board changes on record in total.
Yes, Vip Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-02-0011378).
Vip Pharmaceuticals can be reached through the website vippharma.co.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages